Advertisement
Advertisement

CRVO

CRVO logo

CervoMed Inc. Common Stock

3.95
USD
Sponsored
+0.15
+3.95%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

3.98

+0.03
+0.76%

CervoMed Inc. Common Stock Profile

About

CervoMed Inc. is a clinical-stage biotechnology company advancing CNS-focused therapeutics for patients with a range of degenerative diseases of the brain. The Company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant which inhibits p38MAP kinase alpha. CervoMed Inc., formerly known as Diffusion Pharmaceuticals Inc., is based in BOSTON.

Info & Links

CEO

John Alam

Headquarters

20 Park Plaza, Suite 424 Boston
Boston, MA 02216, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cervomed.com

Auditor

RSM US LLP

Share holders

102

Employees

15

CervoMed Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

36.85M

Enterprise Value

28.61M

Enterprise Value/EBITDA(ttm)

-1.01

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

9.31

Price to Book(mrq)

2.05

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-672.80%

Profit Margin(ttm)

-23922.07%

Return on Equity(ttm)

-96.04%

Return on Invested Capital(ttm)

-106.93%

Return on Assets(ttm)

-82.88%

Income Statement

Revenue(ttm)

4.01M

Revenue Per Share(ttm)

0.43

Gross Profit(ttm)

4.01M

EBITDA(ttm)3

-28.29M

Net Income Available to Common(ttm)

-26.97M

Diluted EPS(ttm)

-2.98

Share Statistics

Beta (5Y Monthly)

-0.67

52-Week Change

-55.62%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.26M

Dividend Yield

0.00%

Float4

5.98M

% Held by Insiders

35.40%

% Held by Institutions

25.15%

Balance Sheet

Total Cash(mrq)

20.86M

Total Cash Per Share(mrq)

2.25

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.91%

Quick Ratio(mrq)

4.91%

Book Value Per Share(mrq)

1.97

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.59

Free Cash Flow(ytd)

-23.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement